Therefore, the combination of BPQD-RMNV-mediated PTT with immune checkpoint-blockade antibodies were found to improve the permeation and efficacy of CD8+ T cells inside the tumor restraining the growth of basal-like breast cancer cells in vitro [74]. The gene discussed is CD8A; the disease is breast cancer.